WHO verifies Niger as the first country in the African Region to eliminate onchocerciasis
On Jan. 30, 2025, the World Health Organization (WHO) congratulated Niger for having met the criteria for onchocerciasis…
Biotechnology | CDC | COVID-19 | Diagnostics | Environmental | Infectious Disease | Life Science News | Therapeutics
Trichuriasis in Human Patients from Côte d’Ivoire Caused by Novel Species resistant to Albendazole/Ivermectin Combination Treatment
On Dec. 18, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported a study with patient…
Higher-Dose and longer duration of Ivermectin not effective with COVID-19
On Feb. 20, 2023, results from a randomized clinical trial of Ivermectin in a higher-hose and longer duration…
Ivermectin ineffective in large study of treatment among patients with Covid-19
On Mar. 31, 2022, researchers in Brazil reported that a study of COVID-19 patients at 12 clinics that…
Merck Statement on Ivermectin use During the COVID-19 Pandemic
On Feb. 4, 2021, Merck affirmed its position regarding use of ivermectin during the COVID-19 pandemic, and do…
Tu Youyou won a share of the Nobel Prize in Physiology or Medicine for her discoveries concerning a novel therapy against Malaria
On Oct. 5, 2015, Tu Youyou was awarded a half share of the Nobel Prize in Physiology or…
Merck began to commercialize Ivermectin as veterinary anti-parasitic drug
In 1981, Merck began commercialize ivermectin as a broad-spectrum veterinary anti-parasitic drug that was originally developed to treat…
Satoshi Ōmura Discovered the pioneering Wonder Drug drug ivermectin
In 1973, Satoshi Ōmura discovered the extraordinary microorganism that produces the avermectins (from which ivermectin is derived) that…